Free Trial

Justin Bowers Analyst Performance

Life Science Tools | Biopharma Services Senior Equity Research Analyst at Deutsche Bank Aktiengesellschaft

Justin Bowers is a stock analyst at Deutsche Bank Aktiengesellschaft in the medical sector, covering 4 publicly traded companies. Over the past year, Justin Bowers has issued 3 stock ratings, including and hold recommendations. While full access to Justin Bowers' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Justin Bowers' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
4 Last 5 Years
Buy Recommendations
25.00% 1 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy25.0%1 ratings
Hold75.0%3 ratings
Sell0.0%0 ratings

Out of 4 total stock ratings issued by Justin Bowers at Deutsche Bank Aktiengesellschaft, the majority (75.0%) have been Hold recommendations, followed by 25.0% Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
50.0% of companies on NASDAQ
2 companies
NYSE
50.0% of companies on NYSE
2 companies

Justin Bowers, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Justin Bowers of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MEDICAL INFO SYS
1 company
25.0%
MED INSTRUMENTS
1 company
25.0%
MEDICAL SERVICES
1 company
25.0%
MED - HMO
1 company
25.0%

Justin Bowers' Ratings History at Deutsche Bank Aktiengesellschaft

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
10x Genomics stock logo
TXG
10x Genomics
8/8/2025Set Price Target$12.29$14.00Hold
Waters Corporation stock logo
WAT
Waters
8/5/2025Set Price Target$282.64$315.00Hold
Medpace Holdings, Inc. stock logo
MEDP
Medpace
7/23/2025Boost Price Target$456.14$430.00Hold